Immediate Radiotherapy or Observation After Surgery for Melanoma Involving Lymph Nodes

PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

November 30, 2008

Study Completion Date

December 31, 2011

Conditions
Malignant MelanomaLymph Node Disease
Interventions
RADIATION

Radiotherapy

48 Gy reference dose in 20 fractions at 5 fractions per week, with a maximum overall treatment time of 30 days.

Trial Locations (22)

1001

Auckland Hospital, Auckland

1585

Mater Hospital - North sydney, Crows Nest

2031

Prince of Wales Hospital, Randwick

2050

Royal Prince Alfred Hospital, Camperdown

2145

Westmead Hospital, Wentworthville

2298

Calvary Mater Newcastle, Newcastle

3181

Alfred Hospital, Prahran

3220

Andrew Love Cancer Care Centre, Geelong Hospital, Geelong

4029

Royal Brisbane Hospital, Herston

4101

Mater QRI, South Brisbane

4102

Princess Alexandra Hospital, Brisbane

4224

East Coast Cancer Centre, Tugun

4710

Christchurch Hospital, Christchurch

5000

Royal Adelaide Hospital, Adelaide

6000

Royal Perth Hospital, Perth

6009

Sir Charles Gairdner Hospital, Nedlands

7250

Launceston General Hospital, Launceston

7902

Wellington Hospital, Wellington

8006

Peter MacCallum Cancer Centre, East Melbourne

Unknown

Hospital do Cancer, São Paulo

Groningen University Hospital, Groningen

Dunedin Hospital, Dunedin

All Listed Sponsors
collaborator

University Medical Center Groningen

OTHER

collaborator

Australian and New Zealand Intensive Care Society Clinical Trials Group

NETWORK

lead

Trans Tasman Radiation Oncology Group

OTHER

NCT00287196 - Immediate Radiotherapy or Observation After Surgery for Melanoma Involving Lymph Nodes | Biotech Hunter | Biotech Hunter